Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate coronavirus disease 2019 (COVID-19)

Fig 2

Probabilities of non-negative responses vs. time (days) for subjects in the HCQ and SOC groups in the multicenter, open-label, randomized controlled trial.

Abbreviations: HCQ: hydroxychloroquine; SOC: standard of care.

Fig 2

doi: https://doi.org/10.1371/journal.pone.0242763.g002